Skip to main content

Forma Therapeutics Holdings Inc (FMTX) Stock Forecast 2025 - AI Price Prediction & Analysis


Forma Therapeutics Holdings Inc (FMTX) AI Stock Price Forecast & Investment Analysis

Forma Therapeutics Holdings Inc Stock Price Chart and Technical Analysis

Loading Forma Therapeutics Holdings Inc interactive price chart and technical analysis...

Forma Therapeutics Holdings Inc (FMTX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Forma Therapeutics Holdings Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Forma Therapeutics Holdings Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Forma Therapeutics Holdings Inc: Forma Therapeutics Holdings Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

Forma Therapeutics Holdings Inc (Stock Symbol: FMTX) is a leading company in the Manufacturing sector , specifically operating within the Biological Product (except Diagnostic) Manufacturing industry.

The organization employs approximately 105 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Forma Therapeutics Holdings Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Forma Therapeutics Holdings Inc: With $101M in annual revenue and -35.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $101 million generating a -35.6% net profit margin .

Market Capitalization: $957 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -33.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Forma Therapeutics Holdings Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Forma Therapeutics Holdings Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Forma Therapeutics Holdings Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Forma Therapeutics Holdings Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Forma Therapeutics Holdings Inc: Market positioning analysis based on available financial and operational metrics.

Forma Therapeutics Holdings Inc strategically competes in the highly dynamic Biological Product (except Diagnostic) Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Forma Therapeutics Holdings Inc (FMTX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Forma Therapeutics Holdings Inc stock analysis.

Loading Forma Therapeutics Holdings Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Forma Therapeutics Holdings Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Forma Therapeutics Holdings Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Forma Therapeutics Holdings Inc: With a P/E ratio of -5.57, the market sees the stock as potentially undervalued.

P/E Ratio -5.57x
P/B Ratio 2.31x
Market Cap $957M
EPS $-1.67
Book Value/Share $8.67
Revenue/Share $2.24
FCF/Share $-2.16
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Forma Therapeutics Holdings Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Forma Therapeutics Holdings Inc: An ROE of -33.6% indicates room for improvement in shareholder value creation.

ROE -33.6%
ROA -31.1%
ROIC -32.5%
Operating Margin -35.0%
Net Margin -35.6%
EBT Margin -36.4%
Tax Rate 61.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Forma Therapeutics Holdings Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Forma Therapeutics Holdings Inc: A current ratio of 16.95 indicates strong liquidity.

Current Ratio 16.95x
Quick Ratio 16.52x
D/E Ratio 0.06x
Financial Leverage 1.12x
Working Capital $623M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Forma Therapeutics Holdings Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Forma Therapeutics Holdings Inc: Free cash flow of $-162M indicates cash challenges that need attention.

Operating Cash Flow $-158M
Free Cash Flow $-162M
Capital Spending $-4M
FCF/Sales -34.8%
CapEx/Sales 0.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Forma Therapeutics Holdings Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Forma Therapeutics Holdings Inc: An asset turnover of 0.45x suggests room for improvement in asset utilization.

Asset Turnover 0.45x
Receivables Turnover 2.4x
Fixed Assets Turnover 16.3x
Days Sales Outstanding 150 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Forma Therapeutics Holdings Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Forma Therapeutics Holdings Inc: With annual revenue of $101M, Forma Therapeutics Holdings Inc demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $101M
Operating Income $-191M
Net Income $-189M
R&D Expense $138M
SG&A Expense $24M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 87%
Cash & Short-term Investments 82%
Total Liabilities 10%
Accounts Receivable 3%
Dividend & Shareholder Information
Shares Outstanding 48M
Growth Metrics (YoY)
EPS Growth -8.4%

Latest Forma Therapeutics Holdings Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Forma Therapeutics Holdings Inc (FMTX) stock price and investment outlook.

📰 We are currently updating our news feed for Forma Therapeutics Holdings Inc. Check back soon for the latest market analysis and company updates.

Forma Therapeutics Holdings Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Forma Therapeutics Holdings Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Forma Therapeutics Holdings Inc Stock Forecast

How accurate are Forma Therapeutics Holdings Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for FMTX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Forma Therapeutics Holdings Inc stock price forecasts?

Our analysis considers Forma Therapeutics Holdings Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Forma Therapeutics Holdings Inc a good investment in 2025?

Based on our AI analysis, Forma Therapeutics Holdings Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Forma Therapeutics Holdings Inc forecasts updated?

Forma Therapeutics Holdings Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Forma Therapeutics Holdings Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Forma Therapeutics Holdings Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...